Ovarian CancerNCT07882485
Effects of Web-Based Ovarian Cancer Awareness Education on Women's Health Beliefs and Risk-Reducing Behaviors
A study testing Web-Based Ovarian Cancer Awareness Education and General Reproductive Health Information in people with Ovarian Cancer, run by Ege University.
Trial summary
This randomized controlled study will evaluate the effects of web-based ovarian cancer awareness education on women's awareness of ovarian cancer, health beliefs, and risk-reducing behaviors. Participants will be randomly assigned to an intervention group or a control group. Read more about this study
- Who is it for?
- Ages 20 to 49 years, women onlyHealthy volunteers can take part
- Conditions the study is for
- Ovarian Cancer
- What is being tested?
- Web-Based Ovarian Cancer Awareness Education and General Reproductive Health Information
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 82 participants
- Where
- No sites listed yet
- Study dates
- Nov 2026to Mar 2027
- Phase
- Interventional
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 to 49 years
- Women only
- Healthy volunteers accepted
- Adult
Who may be able to join
- Women of reproductive age, aged 20 years or older.
- Attending the gynecology outpatient clinic.
- No diagnosis of ovarian cancer.
- No history of surgical menopause.
- No ovarian cancer awareness education within the previous six months.
- Able to read and write Turkish and communicate with the research team.
Show all 9Show fewer
- Having a smartphone and internet access.
- Able to use digital tools.
- Willing to participate voluntarily.
Who cannot join
- Known BRCA1 or BRCA2 gene mutation.
- History of cancer.
Trial locations and contacts
No sites are listed yet. Contact the study team or a site near you to ask about taking part.
About this study
Official title: Effect of Electronic-Based Ovarian Cancer Awareness Education on Women's Health Beliefs and Risk-Reducing Behaviors: A Randomized Study
This randomized controlled study will evaluate the effects of web-based ovarian cancer awareness education on women's awareness of ovarian cancer, health beliefs, and risk-reducing behaviors.
Participants will be randomly assigned to an intervention group or a control group. The intervention group will receive web-based education developed using the Health Belief Model. The educational modules will cover female reproductive organs and cancers, ovarian cancer, symptoms, diagnosis and treatment, risk factors, risk-reducing behaviors, and barriers to taking action.
The groups will be compared using assessments conducted before the education and three months after its completion to determine whether the education improves ovarian cancer awareness, health beliefs, and risk-reducing behaviors.
Read the detailed description
This study is a two-arm, parallel-group randomized controlled trial with baseline and follow-up assessments. It will evaluate the effects of a web-based ovarian cancer awareness education program based on the Health Belief Model on women's ovarian cancer awareness, health beliefs, and risk-reducing behaviors.
The study will recruit women attending the gynecology outpatient clinic at Izmir University of Health Sciences Tepecik Training and Research Hospital, Turkey. A total of 80 participants will be allocated to the intervention and control groups, with 40 participants in each group.
After informed consent and baseline assessments, participants will be randomly assigned in a 1:1 ratio using computer-generated simple randomization. Randomization will be performed by a researcher other than the researcher delivering the intervention. Participants will not be told whether their assigned group is designated as the intervention or control group. All participants will receive information about the educational website. However, because access to the website will be provided at different times, participant masking cannot be assured. The researcher performing the statistical analysis will receive data with the groups coded as A and B, and the meaning of these codes will not be disclosed until the analysis is completed.
Participants in the intervention group will receive individual usernames and passwords to access the educational website. They will be asked to complete seven sequential modules within four weeks. The modules will cover female reproductive organs, gynecological cancers, ovarian cancer and its risk factors, symptoms, diagnosis and treatment, protective factors and risk-reducing behaviors, and perceived barriers and possible solutions.
The educational program will address perceived susceptibility, perceived severity, perceived benefits, perceived barriers, self-efficacy, and cues to action within the Health Belief Model. Participants will complete each module before proceeding to the next. Module completion will be monitored through the website's administrative panel. An ovarian cancer awareness education guide will also be sent through WhatsApp. Weekly messages and telephone contact will support completion of the program.
Participants in the control group will continue to receive routine gynecological care, including clinical assessment, counseling, and diagnostic or treatment services as needed. To maintain contact and reduce loss to follow-up, they will receive weekly educational messages through WhatsApp about general reproductive health topics other than ovarian cancer. They will not have access to the ovarian cancer educational website during the follow-up period. After their final assessment, they will receive the ovarian cancer education guide and access to the website.
Both groups will complete assessments at baseline and three months after the end of the four-week education period, approximately four months after baseline. The control group will follow the same assessment schedule. Data collection instruments will include a participant information form, the Ovarian Cancer Awareness Scale, the Cancer Screening Perception Scale, and the Ovarian Cancer Risk-Reducing Behaviors Form. Website usability will be evaluated using the System Usability Scale among participants who use the educational platform.
The analysis will examine changes over time and differences between the intervention and control groups in ovarian cancer awareness, health beliefs, and risk-reducing behaviors.
- Conditions
- Ovarian Cancer
- Being tested
- Web-Based Ovarian Cancer Awareness Education, General Reproductive Health Information
- Keywords
- Ovarian Cancer, Web-Based Education, Health Belief Model, Health Beliefs, Risk-Reducing Behaviors, Women's Health
- Medical subject headings
- Ovarian Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Web-Based Ovarian Cancer Awareness EducationBehavioural
A four-week web-based education program based on the Health Belief Model, comprising seven sequential modules on female reproductive organs, gynecological cancers, ovarian cancer and risk factors, symptoms, diagnosis and treatment, protective factors and risk-reducing behaviors, and perceived barriers and solutions. Participants will access the website using individual usernames and passwords and complete each module before proceeding to the next. An ovarian cancer awareness education guide will be provided through WhatsApp. Weekly messages and telephone contact will support program completion. Module completion will be monitored through the website's administrative panel.
General Reproductive Health InformationBehavioural
Weekly WhatsApp messages providing general reproductive health information unrelated to ovarian cancer, in addition to routine gynecological care. The messages are intended to maintain contact and reduce loss to follow-up. Participants will not receive ovarian cancer education or access to the educational website until after the final assessment.
| Study group | Role | What they receive |
|---|---|---|
| Web-Based Ovarian Cancer Awareness Education | Experimental | Participants will receive a four-week web-based ovarian cancer awareness education program based on the Health Belief Model. Seven modules will be accessed sequentially using individual usernames and passwords. An ovarian cancer awareness education guide will also be provided through WhatsApp. Weekly messages and telephone contact will support completion, and module completion will be monitored through the website's administrative panel. Participants will continue to receive routine gynecological care. Receives: Behavioral: Web-Based Ovarian Cancer Awareness Education |
| Routine Care and General Reproductive Health Information | Active comparator | Participants will receive routine gynecological care and weekly WhatsApp messages about general reproductive health topics unrelated to ovarian cancer. These messages will maintain contact and help reduce loss to follow-up. Participants will not have access to the ovarian cancer educational website during the follow-up period. After the final assessment, they will receive the ovarian cancer awareness education guide and access to the website. Receives: Behavioral: General Reproductive Health Information |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in Ovarian Cancer Symptom Recall Score
Change from baseline in the symptom recall score of the Turkish version of the Ovarian Cancer Awareness Scale. Participants will list ovarian cancer symptoms in an open-ended question. Each correctly recalled symptom will receive 1 point, with scores ranging from 0 to 10. Higher scores indicate greater awareness of ovarian cancer symptoms. Changes will be compared between the intervention and control groups.
Measured: Baseline and three months after completion of the four-week education period (approximately four months after baseline).
Change in Ovarian Cancer Symptom Recognition Score
Change from baseline in the symptom recognition score of the Turkish version of the Ovarian Cancer Awareness Scale. Participants will identify whether each of 10 listed symptoms could be a symptom of ovarian cancer, using "yes," "no," or "don't know" responses. Each "yes" response will receive 1 point; "no" and "don't know" responses will receive 0 points. Scores range from 0 to 10, with higher scores indicating greater symptom recognition. Changes will be compared between the intervention and control groups.
Measured: Baseline and three months after completion of the four-week education period (approximately four months after baseline).
Change in Ovarian Cancer Risk Factor Recall Score
Change from baseline in the risk factor recall score of the Turkish version of the Ovarian Cancer Awareness Scale. Participants will list ovarian cancer risk factors in an open-ended question. Each correctly recalled risk factor will receive 1 point, with scores ranging from 0 to 12. Higher scores indicate greater awareness of ovarian cancer risk factors. Changes will be compared between the intervention and control groups.
Measured: Baseline and three months after completion of the four-week education period (approximately four months after baseline).
Change in Ovarian Cancer Risk Factor Awareness Score
Change from baseline in the risk factor awareness score of the Turkish version of the Ovarian Cancer Awareness Scale. This section includes 12 items rated on a five-point Likert scale, from 1 (strongly disagree) to 5 (strongly agree). Scores range from 12 to 60. Higher scores indicate greater awareness of ovarian cancer risk factors. Changes will be compared between the intervention and control groups.
Measured: Baseline and three months after completion of the four-week education period (approximately four months after baseline).
Secondary outcomes (6)
Change in Perceived Severity Subscale Score of the Cancer Screening Perception Scale
Change from baseline in the perceived severity subscale score of the Turkish version of the Cancer Screening Perception Scale. This subscale consists of four items rated on a six-point Likert scale. Scores range from 4 to 24. According to the scoring description, higher scores indicate lower perceived severity. Changes will be compared between the intervention and control groups.
Measured: Baseline and three months after completion of the four-week education period (approximately four months after baseline).
Change in Perceived Susceptibility Subscale Score of the Cancer Screening Perception Scale
Change from baseline in the perceived susceptibility subscale score of the Turkish version of the Cancer Screening Perception Scale. This subscale consists of five items rated on a six-point Likert scale. Scores range from 5 to 30. Higher scores indicate lower perceived susceptibility. Changes will be compared between the intervention and control groups.
Measured: Baseline and three months after completion of the four-week education period (approximately four months after baseline).
Change in Perceived Benefits Subscale Score of the Cancer Screening Perception Scale
Change from baseline in the perceived benefits subscale score of the Turkish version of the Cancer Screening Perception Scale. This subscale consists of six items rated on a six-point Likert scale. Scores range from 6 to 36. Higher scores indicate greater perceived benefits of cancer screening tests. Changes will be compared between the intervention and control groups.
Measured: Baseline and three months after completion of the four-week education period (approximately four months after baseline).
Change in Perceived Barriers Subscale Score of the Cancer Screening Perception Scale
Change from baseline in the perceived barriers subscale score of the Turkish version of the Cancer Screening Perception Scale. This subscale consists of five items rated on a six-point Likert scale. Scores range from 5 to 30. Higher scores indicate greater perceived barriers to cancer screening. Changes will be compared between the intervention and control groups.
Measured: Baseline and three months after completion of the four-week education period (approximately four months after baseline).
Change in Cues to Action Subscale Score of the Cancer Screening Perception Scale
Change from baseline in the cues to action subscale score of the Turkish version of the Cancer Screening Perception Scale. This subscale consists of six items rated on a six-point Likert scale. Scores range from 6 to 36. According to the scoring description, higher scores indicate a greater number of self-reported symptoms that may prompt action. Changes will be compared between the intervention and control groups.
Measured: Baseline and three months after completion of the four-week education period (approximately four months after baseline).
Change in Item-Level Responses on the Ovarian Cancer Risk-Reducing Behavior Awareness Form
A researcher-developed 15-item form will assess self-reported lifestyle behaviors, symptom-related healthcare seeking, and intentions regarding physician-recommended diagnostic or preventive procedures. Each item has five response categories: never, rarely, sometimes, often, and always. For each item, the percentage of participants selecting each response category will be calculated at baseline and follow-up, and changes will be compared between groups. Items will be analyzed separately; no total score will be calculated. More frequent genital talc use will not be interpreted as a favorable change.
Measured: Baseline and three months after completion of the four-week education period (approximately four months after baseline).
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted20 Oct 2026
- Study startNov 2026 (estimated)
- Primary completionMar 2027 (estimated)
- Study completionMar 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Ovarian CancerStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 82 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Ege University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Seda DORUKOGLU, Ege University
- Investigators
- Zeynep Daşıkan, Principal investigator, Ege University, Faculty of Nursing
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07882485
- Sponsor's protocol ID
- 25-5T/111
- Status last verified
- Oct 2026
- First submitted
- 13 Oct 2026
- Last updated
- 22 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No